Advertisement
Canada markets closed

  • S&P/TSX

    21,714.54
    -297.08 (-1.35%)
     

  • S&P 500

    5,035.69
    -80.48 (-1.57%)
     

  • DOW

    37,815.92
    -570.17 (-1.49%)
     

  • CAD/USD

    0.7258
    -0.0003 (-0.05%)
     

  • CRUDE OIL

    81.16
    -0.77 (-0.94%)
     

  • Bitcoin CAD

    83,058.47
    -5,165.34 (-5.85%)
     

  • CMC Crypto 200

    1,283.80
    -55.26 (-4.13%)
     

  • GOLD FUTURES

    2,298.30
    -4.60 (-0.20%)
     

  • RUSSELL 2000

    1,973.91
    -42.12 (-2.09%)
     

  • 10-Yr Bond

    4.6860
    +0.0720 (+1.56%)
     

  • NASDAQ futures

    17,505.75
    -65.50 (-0.37%)
     

  • VOLATILITY

    15.65
    +0.98 (+6.68%)
     

  • FTSE

    8,144.13
    -2.90 (-0.04%)
     

  • NIKKEI 225

    38,076.62
    -329.04 (-0.86%)
     

  • CAD/EUR

    0.6806
    +0.0004 (+0.06%)
     

23andMe CEO Wojcicki considering taking firm private, filing shows

Reuters
·1 min read

(Reuters) - 23andMe co-founder and chief executive Anne Wojcicki is considering making an offer to buy the genetics testing company in a potential go-private transaction, a regulatory filing on late Wednesday showed.

Last week, Wojcicki notified members of the board's special committee that she is considering a potential go-private transaction for 23andMe and indicated that she would begin speaking to partners and financing sources.

23andMe declined to comment on the filing and Wojcicki did not immediately respond to a Reuters' request for comment.

Last year, the company informed several customers of a data breach in the "DNA Relatives" feature that allowed them to compare ancestry information with users worldwide.

ADVERTISEMENT

23andMe, best known for its saliva-based test kits that offer users a glimpse into their genetic ancestry went public in 2021 through a blank-check firm, backed by Virgin Group founder Richard Branson, in a deal that valued the merged entity at $3.5 billion.

(Reporting by Mrinmay Dey in Bengaluru; Editing by Eileen Soreng)